We are living in a time of incredible advances in AI, automation, and synthetic biology, which are ushering in breakthroughs that were previously in the realm of science fiction. Maryanna Saenko, Jaleh Daie, and other investors are recognizing the power of synthetic biology to solve global challenges and create entirely new industries and markets with multi-billion-dollar potential. These investors are supporting founder-led, mission-driven companies forging the future at the cutting edge of disruptive technology and new industry formation.
